Document is current
Any future updates will be listed below
-
Authors
Hagens, Marloes H. J. https://orcid.org/0000-0002-7115-6833
Golla, Sandeep V.
Wijburg, Martijn T.
Yaqub, Maqsood
Heijtel, Dennis
Steenwijk, Martijn D.
Schober, Patrick
Brevé, John J. P.
Schuit, Robert C.
Reekie, Tristan A.
Kassiou, Michael
van Dam, Anne-Marie
Windhorst, Albert D.
Killestein, Joep
Barkhof, Frederik
van Berckel, Bart N. M.
Lammertsma, Adriaan A.
-
Funding
Funding for this research was provided by:
Stichting MS Research (programme grant 14-358e)
Amsterdam Neuroscience (Proof of Concept Fund NCA 2013)
- License Information
-
More Information
Article History
Received: 15 June 2018
Accepted: 30 October 2018
First Online: 13 November 2018
Ethics approval and consent to participate
: This study was approved by the Medical Ethics Review Board of the VU University Medical Center and was registered under the number 2014.356. All subjects gave written informed consent prior to participation.
: Not applicable.
: DH is employed by Philips Healthcare. JK has accepted speaker and consultancy fees from Merck-Serono, Teva, Biogen, Genzyme, Roche and Novartis. FB is supported by the NIHR UCLH Biomedical Research Centre and serves as a consultant for Bayer-Schering Pharma, Sanofi-Aventis, Genzyme, Biogen-Idec, Teva, Novartis, Roche, Synthon BV and Jansen Research. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
